Clinical Trial Update: Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL [Phase 3]

View source ↗

Summary

This entry notes a Phase 3 clinical trial comparing the VHAG regimen to traditional chemotherapy in newly diagnosed early T-cell precursor acute lymphoblastic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• VHAG

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: ETP-ALL | Phase 3 | Status: RECRUITING